InvestorsHub Logo
Followers 4
Posts 388
Boards Moderated 0
Alias Born 10/28/2013

Re: smarterer post# 149898

Tuesday, 10/16/2018 11:53:56 AM

Tuesday, October 16, 2018 11:53:56 AM

Post# of 430248

That bid would have to be at least $150 to get the attention of the folks that matter, e.g., Baker Brothers, but even then I think is likely to fail. A winning bid might require a bid of $250 or more in January 2019.



Are you serious???

Look - I really really hope you are right. Hey I sure as hell could use the extra $5 - $10 million IF it makes $200 by Jan 2019.

I really really doubt we'll even come close to touching that price in the next 6 months.

There are plenty of smart posters on this board who know a lot about EPA science and cardiology - I profited off their knowledge and I give them a ton of credit there. But this is what I do: I'm a BD and Commercial guy for a smallish pharma. I structure deals and milestone payments.

While I'll readily admit I am no "retired ceo" or C-suite level, I know enough about the industry to say that if AMRN is bought out at $100 in the next 12 months, even assuming no dilution (dilution would make the total deal size even bigger), it would probably be the biggest deal of its kind - ever.

The only similar comparison would be AbbVie buying Pharmacyclics for $21B, which was a huge deal in itself. This $34B acquisition would dwarf that by far.

There have been bigger deals, of course. But those were companies with far bigger drug pipelines and significantly higher revenues. Amarin has a single drug (albeit promising indications). I think it'll attract some offers, but nothing in that price range - IMHO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News